Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Transmucosal Ketamine in Post Stroke Depression

NCT04876066 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.

NCT NCT04876066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04876066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Transmucosal Ketamine in Post Stroke Depression
Lead sponsor
West Virginia University
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2020
Completion date
November 30, 2022
Enrollment
21 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke depression